Compare Viatris Inc (VTRS) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Williams Companies Inc — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Williams Companies Inc trades at $73.43 (market cap $90.70B). The key difference: Williams Companies Inc is far larger — about 4.6× Viatris Inc's market cap, and Viatris Inc is trading nearer its 52-week high, Williams Companies Inc nearer its low. Which is the better fit depends on your goals.
| VTRS | WMB | |
|---|---|---|
Market Cap | $19.79B | $90.70B |
Sector | Health | Energy |
52-Week High | $17.39 | $79.40 |
52-Week Low | $8.74 | $56.51 |
Enterprise Value | $32.00B | $120.08B |
Dividend Yield | 2.83% | 2.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
